A nationwide study across Ireland revealed that the vast majority of patients do not understand the core concepts underpinning a clinical trial.
Browsing: Clinical trials
We spoke with a key study investigator of the multiple myeloma ENDEAVOR trial to explore the trial in more detail and to discover the potential clinical application of its overall survival findings.
A recent clinical trial presents new data indicating durvalumab improves progression-free survival in patients with stage III non-small-cell lung cancer (NSCLC).
This review reports the results of application of short peptides in glioma therapy clinical trials, their rises and falls.
In this interview with Francesco Lo-coco we discussed a randomized clinical trial conducted with the drug Trisenox as well as, the genetic characterization, monitoring and treatment of hematologic tumors, particularly acute promyelocytic leukemia.
What are the current limitation with clinical trials for AML? This review discusses trial end points, patient enrollment, cost of drug discovery and patient heterogeneity and future treatment of AML.
In this editorial from Melanoma Management the authors examine melanoma clinical trials with a focus upon targeted therapies and melanoma vaccines.
Researchers have identified a novel potential therapeutic target for an aggressive form of pediatric glioma.
New clinical trial data indicates that pembrolizumab immunotherapy both significantly increases survival in bladder cancer and has activity against mucosal melanoma.
This opinion article from Immunotherapy looks at how antigen-directed therapies could hold potential for the treatment of acute myeloid leukemia and the challenges of their use to date.